HOME   |    PDF   |   


Insights from the molecular docking analysis of colistin with the PmrA protein model from Acinetobacter baumannii



Shalini Ganeshan1, Mohammad Reza Shakibaie2,3,*& Rajaguru Rajagopal4



1Department of Biotechnology, Tips college of arts and science, Coimbatore, Tamil Nadu 641107, India; 2Department of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran; 3Environmental Health Engineering Research Center, Kerman University of Medical Science, Kerman, Iran; 4Research Scholar Department of Pharmaceutics, Mother Theresa Post Graduate and Research Institute of Health Sciences, Pondicherry-605006, India. *Corresponding author



Shalini Ganeshan - E-mail: shalininov2015@gmail.com; Mohammad Reza Shakibaie - E-mail: mr_shakibaei@kmu.ac.ir; Rajaguru Rajagopal - E-mail: rajaguru94mrv@gmail.com


Article Type

Research Article



Received October 27, 2021; Revised December 10, 2021; Accepted December 10, 2021, Published January 31, 2022



Acinetobacter baumannii (AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 μg/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium.



Acinetobacter baumannii, protein modeling, model quality, molecular docking.



Ganeshan et al. Bioinformation 18(1): 41-49 (2022)


Edited by

P Kangueane






Biomedical Informatics



This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.